Method for in vitro molecular evolution of protein function

Details Method for in vitro molecular evolution of protein function Method for in vitro molecular evolution of protein function

2006-01-24

2006-01-24

Lu, Frank W. (Department: 1634)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

C435S006120, C435S091100, C436S094000, C536S023100, C536S024300, C536S024330

Reexamination Certificate

active

06989250

ABSTRACT:
The present invention relates to a method for in vitro creation of molecular libraries evolution of protein function. Particularly, it relates to variability and modification of protein function by shuffling polynucleotide sequence segments. A protein of desired characteristics can be obtained by incorporating variant peptide regions (variant motifs) into defined peptide regions (scaffold sequence). The variant motifs can be obtained from parent DNA which has been subjected to mutagenesis to create a plurality of differently mutated derivatives thereof or they can be obtained from in vivo sequences. These variant motifs can then be incorporated into a scaffold sequence and the resulting coded protein screened for desired characteristics. This method is ideally used for obtaining antibodies with desired characteristics by isolating individual CDR DNA sequences and incorporating them into a scaffold which may, for example, be from a totally different antibody.

REFERENCES:
patent: 5023171 (1991-06-01), Ho et al.
patent: 5252479 (1993-10-01), Srivastava
patent: 5573907 (1996-11-01), Carrino et al.
patent: 5605793 (1997-02-01), Stemmer
patent: 5811238 (1998-09-01), Stemmer et al.
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5834252 (1998-11-01), Stemmer et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 6159690 (2000-12-01), Borrebaeck et al.
patent: 6335160 (2002-01-01), Patten et al.
patent: 6495321 (2002-12-01), Borredaeck et al.
patent: 0 368 684 (1990-05-01), None
patent: 0 415 731 (1991-03-01), None
patent: 0 456 304 (1991-11-01), None
patent: 0 911 396 (1999-04-01), None
patent: 0 934 999 (1999-08-01), None
patent: 9701425.2 (1997-01-01), None
patent: WO 90/07936 (1990-07-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/07075 (1992-04-01), None
patent: WO 92/15702 (1992-09-01), None
patent: WO 93/07282 (1993-04-01), None
patent: WO 94/12632 (1994-06-01), None
patent: WO 95/22625 (1995-08-01), None
patent: WO 96/17056 (1996-06-01), None
patent: WO 96/23873 (1996-08-01), None
patent: WO 97/08320 (1997-03-01), None
patent: WO 97/20078 (1997-06-01), None
patent: WO 98/27230 (1998-06-01), None
patent: WO 98/32845 (1998-07-01), None
patent: WO 98/42832 (1998-10-01), None
patent: WO 98/58080 (1998-12-01), None
Prickett, K.S. et al. “Calcium-Dependent Antibody for Identification and Purification of Recombinant Proteins”; Bio Techniques 7: 580-589 (1989).
Horton, R.M. et al. “Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension”; Gene 77: 61-68 (1989).
Huse, W.D. et al. “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”; Science 246: 1275-1281 (1989).
Kikuchi, M. et al. “An effective family shuffling method using single-stranded DNA”; Gene 243: 133-137 (2000).
Kim, Y. et al. “Bacterial Cell Surface Display of an Enzyme Library for Elective Screening of Improved Cellulase Variants”; Appl. Environ. Microbiol. 66:788-793 (2000).
Kobayashi, N. et al. “Analysis of Assembly of Synthetic Antibody Fragments: Expression of Functional scFv with Predefined Specificity”; BioTechniques 23: 500-503 (1997).
Kuipers, O.P. et al. “Improved site-directed mutagenesis method using PCR”; Nucleic Acids Research 19(16): 4558 (1991).
Larrick, J.W. et al. “Rapid Cloning of Rearranged Immunoglobulin Genes from Human Hybridoma Cells Using Mixed Primers and the Polymerase Chain Reaction”; Biochem. Biophys. Res. Com. 160: 1250-1256 (1989).
Leung, D.W. et al. “A Method for Random Mutagenesis of a Defined DNA Segment Using a Modified Polymerase Chain Reaction”; Technique 1: 11-15 (1989).
Lewin, B. “Processing Is Necessary To Produce Some RNAs”; Genes IV, p. 272 (1990).
Lu, T. et al. “Kinetics and mechanism of BAL 31 nuclease action on small substrates and single-stranded DNA”; Biochimica et Biophysica Acta 1251: 125-138 (1995).
Luqmani, Y.A. et al. “Subtraction Hybridization Cloning of RNA Amplified from Different Cell Populations Microdissected from Cryostat Tissue Sections”; Analytical Biochemistry 222: 102-109 (1994).
Marks, J.D. et al. “By-Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling”; Bio/Technology 10: 779-783 (1992).
McCafferty, J. et al. “Phage antibodies: filamentous phage displaying antibody variable domains”; Nature 348: 552-554 (1990).
Moore, J.C. et al. “Directed evolution of a para-nitrobenzyl esterase for aqueous-organic solvents”; Nature Biotechnol. 14: 458-467 (1996).
Mottershead, D. et al. “Baculoviral Display of the Green Fluorescent Protein and Rubella Virus Envelope Proteins”; Biochem. Biophysis. Res. Com. 238: 717-722 (1997).
Orlandi, R. et al. “Cloning immunoglobulin variable domains for expression by the polymerase chain reaction”; Proc. Natl. Acad. Sci. USA 86: 3833-3837 (1989).
Ostermeier, M. et al. “A combinatorial approach to hybrid enzymes independent of DNA homology”; Nature Biotechnol. 17: 1205-1209 (1999).
Parmley, S.F. et al. “Antibody-selectable filamentous fd phage vectors: affinity purification of target genes”; Gene 73: 305-318 (1988).
Roberts, S. et al. “Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering”; Nature 328: 731-734 (1987).
Schier, R. et al. “Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding Site”; J. Mol. Biol. 263: 551-567 (1996).
Schmidt, E.R. “Exonuclease digestion of chromosomes for in situ hybridization”; Nucl. Acid Research 16: 10381 (1988).
Sock, E. et al. “DNA Replication of Human Polyomavirus JC Is Stimulated by NF-l in Vivo”; Virology 182: 298-308 (1991).
Söderlind, E. et al. “Domain libraries: Synthetic diversity for de novo design of antibody V-regions”; Gene 160: 269-272 (1995).
Stemmer, W.P.C., “Rapid evolution of a protein in vitro by DNA shuffling”; Nature 370: 389-391 (1994).
Stemmer, W.P.C. “DNA shuffling by random fragmentation and reassembly: In vitro recombination for molecular evolution”; Proc. Natl. Acad. Sci. USA 91: 10747-10751 (1994).
Vaish, N.K. et al. “In vitro selection of a purine nucleotide-specific hammerhead-like ribozyme”; Proc. Natl. Acad. Sci. USA 95: 2158-2162 (1998).
Warren, Mark S. et al. “A Rapid Screen of Active Site Mutants in Glycinamide Ribonucleotide Transformylase”; Biochemistry 35: 8855-8862 (1996).
Yang, W. et al. “CDR Walking Mutagenesis for the Affinity of a Potent Human Anti-HIV-1 Antibody into the Picomolar Range”; J. Mol. Biol. 254: 392-403 (1995).
Zhang, J. et al. “Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening”; Proc. Natl. Acad. Sci. USA 94: 4504-4509 (1997).
Christians, F.C. et al. “Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling”; Nature Biotechnol. 17: 259-264 (1999).
Crameri, A. et al. “Combinatorial Multiple Cassette Mutagenesis Creates All the Permutations of Mutant and Wild-Type Sequences”; BioTechniques 18: 194-196 (1995).
Crameri, A. et al. “Molecular evolution of an arsenate detoxification pathway by DNA shuffling”; Nature Biotechnol. 15: 436-438 (1997).
Crameri, A. et al. “DNA shuffling of a family of genes from diverse species accelerates directed evolution”; Nature 391: 288-291 (1998).
Deng, S. et al. “Simultaneous randomization of antibody CDRs by a synthetic ligase chain reaction strategy”; Nucleic Acids Research 21(18): 4418-4419 (1993).
Dower, W.J. et al. “High efficiency transformation ofE. coliby high voltage electroporation”; Nucleic Acids Re

Affiliated with

Also associated with

Rating

Method for in vitro molecular evolution of protein function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for in vitro molecular evolution of protein function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for in vitro molecular evolution of protein function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3567657